Toxic Exposures and the Microbiome Ellen Silbergeld Johns Hopkins University Bloomberg School of Public Health Baltimore MD 21218

Slides:



Advertisements
Similar presentations
Dosimetry in Risk Assessment and a bit More Mel Andersen McKim Conference QSAR and Aquatic Toxicology & Risk Assessment June 27-29, 2006.
Advertisements

The Microbiome: What’s the immune system got to do with it?
THE ENVIRONMENT and CHILDRENS HEALTH : THE ROLE OF RESEARCH IN UNDERSTANDING AND PREVENTING RISK Prof. Ellen K Silbergeld Johns Hopkins University Bloomberg.
Characterizing Uncultured Bacteria Michael Wagner Division of Microbial Ecology University of Vienna.
William H. Farland, Ph.D. Acting Deputy Assistant Administrator for Science Office of Research and Development U.S. ENVIRONMENTAL PROTECTION AGENCY Biomarkers:
INTRODUCTION TO TOXICOLOGY
6/10/2015 ©T. C. Hazen #1 Center for Environmental Biotechnology Center for Environmental Biotechnology Rapid deduction of bacteria stress response pathways:
Microbial response to changing environments. Changes in physiology Inherited reversible changes.
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
Introduction to molecular networks Sushmita Roy BMI/CS 576 Nov 6 th, 2014.
Introduction to Molecular Epidemiology Jan Dorman, PhD University of Pittsburgh School of Nursing
The Microbiome and Metagenomics
ARSENIC EXPOSURE: PERSPECTIVE ON RISK ASSESSMENT RABIYA SHABNAM M.S.Student ECS program NDSU
1 2. Basic Concepts of Disease in Populations Peter Davies/Cord Heuer.
Unit 1: The Language of Science  communicate and apply scientific information extracted from various sources (3.B)  evaluate models according to their.
The BIO Directorate Microbial Biology Emphasis BIO Advisory Committee April, 2005.
Integrated Environmental Health Middle School Project University of Washington © What is Environmental Health? A Student Introduction Outside Inside.
Lecture #3 Hazards and their effects. Epidemiology = The study of the distribution and causes of disease and injuries in human populations. – Epidemiologists.
National Institutes of Health National Institute of General Medical Sciences FINDINGS Chemical World Toxicologist Serrine Lau: Investigating Molecular.
Web of Causation; Exposure and Disease Outcomes Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
Safety of Ingredients and Formulations Raman Govindarajan, MD, PhD. Regional Director, Medical and Scientific Affairs Johnson and Johnson Asia Pacific.
Environmental Carcinogenesis White Coat Wonders Lisa Lam Zara Khan.
The Human Microbiome.
The NIH Roadmap and the Human Microbiome Project Francis S. Collins, M.D., Ph.D. National Human Genome Research Institute April 22, 2007.
INTRODUCTION Nutrigenomics Dr. Muhamad Firdaus
EPA’s Strength in Both GEOSS & ESIP; Environmental Health Decisionmaking January 10, 2008 George Gray, Ph.D. Assistant Administrator EPA Office of Research.
The Human Microbiome: PSC, IBD, and the Gut-Liver Axis
713 Lecture 15 Host metagenomics. Progression of techniques Culture based –Use phenotypes and genotypes to ID Non-culture based, focused on 16S rDNA –Clone.
Statistical Analysis of Mouse Gut Microbiota Alex Tran Computer Systems Lab
Innate Immunity Innate immunity is an evolutionary ancient form of host defense that serves to limit infection from the 1st minutes to hours after exposure.
Of Massachusetts Department ENVIRONMENTAL PROTECTION NE-SRA June 19, 2007 Why are Kids Different? Underlying Biological and Physiological Characteristics.
TOXICOGENOMICS.
Gene Expression and Epigenetic Regulation JESSICA LAINE AND ELIZABETH MARTIN.
Gut Microbiota: Effects and Benefits
Bacterial Biofilms as a Complex Community Tracy K. Teal D. K. Newman and B. J. Wold Labs Complexity Club August 13, 2003.
NUATRC/TCEQ Air Toxics Workshop October Air Toxics Air Toxics: What We Know, What we Don’t Know, and What We Need to Know Human Health Effects –
Open Your Mouth & Say “Ah”
The Human Micro-biome. What is the Human Microbiome Microbial communities exist in many places such as in the soil, in the ocean and in every plant and.
The Genomics: GTL Program Environmental Remediation Sciences Program Spring Workshop April 3, 2006.
Inflammatory Bowel Diseases November 19, 2007 NCDD Meeting Chair: Daniel K. Podolsky, MD Vice Chair: Eugene B. Chang, MD.
The Environment and Human Health
ISSUES & CHALLENGES Adaptation, translation, and global application DiClemente, Crosby, & Kegler, 2009.
1 Modelling and Simulation EMBL – Beyond Molecular Biology Physics Computational Biology Chemistry Medicine.
Cumulative Risk Assessment: A Critical Step Forward in Human Health Protection Deborah A. Cory-Slechta Department of Environmental Medicine University.
Occupational Respiratory Disorders Zafar Fatmi Associate Professor & Head Division of Environmental Health Sciences Department of Community Health Sciences.
What’s All the Fuss About the Microbiome?
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Discovery of Multiple Differentially Methylated Regions
Nicholas A. Bokulich, Martin J. Blaser  Cell Metabolism 
Human Gut Microbiome: Function Matters
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Losing weight for a better health: Role for the gut microbiota
The Cellular Phase of Alzheimer’s Disease
Food Nutrition and Public Health
Through the Scope Darkly: The Gut Mycobiome Comes into Focus
The Human Microbiome before Birth
Nitzan Koppel, Emily P. Balskus  Cell Chemical Biology 
INTRODUCTION Nutrigenomics Dr. Muhamad Firdaus
by Laura V. Blanton, Michael J. Barratt, Mark R
Three major barriers to the integration of metagenomics into pharmacology and toxicology. Three major barriers to the integration of metagenomics into.
Microbes, Microbiota, and Colon Cancer
Microbial contribution to drug metabolism.
Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance  Ankur Singh, Ilana Brito, Jan Lammerding 
Introduction to Pharmacogenetics
Jan – Dec RuminOmics Connecting the animal genome, the intestinal microbiome and nutrition to enhance the efficiency of ruminant.
Gut Microbiome Studies
Genetics of Microbial Biodegradation
Matthew D. Weitzman, Jonathan B. Weitzman  Cell Host & Microbe 
(A) Metabolic niches in the gut microbiome.
Presentation transcript:

Toxic Exposures and the Microbiome Ellen Silbergeld Johns Hopkins University Bloomberg School of Public Health Baltimore MD

AAAS San Jose February 2015 Acknowledgements Rodney Dietert – co-author and co-developer of a new model for environmental health Martin Blaser and Clair Fraser – inspiration for thinking outside the box about the microbiome Markus Hilpert for reminding me about bioremediation

AAAS San Jose February 2015 MICROBIOME: “WHO ARE WE?” Martin Blaser EMBO 2006* The entirety of the microbial [bacterial] world within a defined domain or space, including all the genomes and genes of the members of the microbiome The microbial world, and its inputs and outputs The interactions (genomic, proteomic, etc) between the microbial world and its domain [host, organ system, ecological niche, etc] * ANSWER: WE ARE MOSTLY BACTERIAL CELLS 10:1

AAAS San Jose February 2015 Option 3: the ecological approach Mutualism and interdependence among organisms and the landscape Selection and evolutionary change within space and time Social organization and intra/inter community discourse

AAAS San Jose February 2015 Toxic exposures and the microbiome Target and transducer of toxicant actions Gatekeeper functions at the portal of entry Mediator of host/environment interactions –Susceptibility factors

AAAS San Jose February 2015 The microbiome as transducer of toxic exposures Bischoff 2011

AAAS San Jose February 2015 Gatekeeper at the portal of entry Portals of entry and routes of exposure: Wallace, US EPA TEAM study 1987

AAAS San Jose February 2015 The current paradigm: linking exposures and outcomes by opening the “black box” (NRC 1987)

AAAS San Jose February 2015 The standard model of how external exposures are transferred and transformed within the organism: ADME and PBPK Corley et al 1990 Absorption Distribution Metabolism Excretion Physiologically Based Pharmaco/toxico Kinetics

AAAS San Jose February 2015 The microbiome in the picture: Dietert and Silbergeld 2015

AAAS San Jose February 2015 The new “frontier” of ADME – the gut microbiome ( Klunemann et al Trends Biotechnol 2014).

AAAS San Jose February 2015 The expanded version: what are the implications for understanding and studying gene:environment interactions Whose genes? –Human or other organism –Microbiome Which genes? –Human genes don’t change –The microbial metagenome can change What is the relative contribution of human and microbial genes to metabolism of toxic agents [activation and detoxification]

AAAS San Jose February 2015 Most of the genetic information in “us” (human + microbiota) is bacterial NAS The Social Biology of Microbial Communities NAP

AAAS San Jose February 2015 Does the gatekeeper modulate exposure:response relationships related to metabolism? Macrocosm studies --Tan and Bartha (1998) AEM Mercury methylation and demethylation by environmental bacteria [Desulfovibrio desulfuricans] that are also present in the human gut

AAAS San Jose February 2015 Not such a new story: bacteria and environmental remediation: Desulfitobacterium hafniense and polychlorophenols Villemur R, Phil Trans R Soc 2013

AAAS San Jose February 2015 Challenging our research designs: where is arsenic methylated? Current hypotheses –Methylation of inorganic arsenic occurs after absorption and distribution within the body –The overall patterns of arsenic and its metabolites are predictive of risks of toxicity –Polymorphisms in human genes encoding these metabolic pathways are associated with differential patterns of arsenic metabolism

AAAS San Jose February 2015 Human pathways of arsenic metabolism (Marnell et al 2003)

AAAS San Jose February 2015 Genetic polymorphisms in human arsenic methylating genes and arsenic metabolism Wu et al 2014 TAP

AAAS San Jose February 2015 Arsenic methylation status and risks of lung cancer Melak et al TAP 2014

AAAS San Jose February 2015 BUT bacteria within the human gut microbiome can also metabolize arsenic through the same pathway Kruger et al 2013

AAAS San Jose February 2015 Human gut microbiome ex vivo metabolizes iAs () Van de Wiele et al EHP 2010

AAAS San Jose February 2015 Disturbing the gut microbiome alters metabolism of arsenic in mice: Helicobacter infection of mice  Δmicrobiome  arsenic metabolism Lu et al 2013

AAAS San Jose February 2015 The host is still in the picture: the microbiome and its environmental niche in the gut Bischoff 2011

AAAS San Jose February 2015 The gate keeper is also a watchman: signaling between the host and the microbiome Hooper et al Science 336: , 2012

AAAS San Jose February 2015 Altering the immune phenotype in mice alters the gut microbiome and arsenic metabolism Lu et al 2014

AAAS San Jose February 2015 So host genetics affect the microbiome

AAAS San Jose February 2015 Human genetic contribution to arsenic metabolism [Tellez Plaza et al 2011]

AAAS San Jose February 2015 RESEARCH QUESTIONS: What is the relative contribution of the gut [lung, skin, etc] microbiome to toxicant metabolism? How do we include the microbiome in epidemiological studies? What additional cofactors should we add to epidemiological studies? What opportunities does the microbiome present for interventions to protect exposed persons from toxicity?

AAAS San Jose February 2015 More complexity – adding the microbiome into systems toxicology

AAAS San Jose February 2015 “We’re not in Kansas anymore, Toto” [with apologies to Curt Klaassen]